Evidence map›Paper›PMID 41743173›Full record

ArticleJCEM case reports2026

Isolated Adrenocorticotropin Deficiency With Depressive Symptoms.

Kentaro Mikami, Yasushi Oiwa, Mitsuhiro Kometani, Takashi Yoneda, Masashi Oe, Yuko Katsuda

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kentaro MikamiDepartment of Diabetes and Endocrinology, Fukui Prefectural Hospital, Fukui, Fukui 910-8526, Japan.
Yasushi OiwaDepartment of Health Promotion and Medicine of Future, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa 920-8641, Japan.
Mitsuhiro KometaniDepartment of Health Promotion and Medicine of Future, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa 920-8641, Japan.ORCID https://orcid.org/0000-0003-0461-3018
Takashi YonedaDepartment of Health Promotion and Medicine of Future, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa 920-8641, Japan.ORCID https://orcid.org/0000-0002-0921-158X
Masashi OeDepartment of Diabetes and Endocrinology, Fukui Prefectural Hospital, Fukui, Fukui 910-8526, Japan.
Yuko KatsudaDepartment of Diabetes and Endocrinology, Fukui Prefectural Hospital, Fukui, Fukui 910-8526, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isolated adrenocorticotropin deficiency (IAD) is a rare cause of adrenal insufficiency, often presenting with nonspecific symptoms that can be misattributed to mental disorders or gastrointestinal diseases, particularly in older adults. IAD is characterized by profoundly reduced adrenocorticotropin (ACTH) secretion with preserved secretion of other anterior pituitary hormones. We describe an 81-year-old woman with persistent nausea, vomiting, anorexia, and depressive symptoms that did not respond to standard antidepressant agents. During 2 months of hospitalization, she progressed to impaired consciousness. Routine laboratory tests and magnetic resonance imaging of the pituitary region revealed no abnormalities. Hormonal evaluation showed markedly low levels of cortisol and ACTH. A corticotropin-releasing hormone stimulation test confirmed IAD. The patient had no history of glucocorticoid use, immune checkpoint inhibitors therapy, or other causes of adrenal insufficiency. Intravenous hydrocortisone replacement therapy at 50 mg daily led to a rapid improvement in consciousness and resolution of psychiatric gastrointestinal symptoms. This case emphasizes the importance of considering IAD in older patients presenting with unexplained neuropsychiatric and gastrointestinal symptoms, particularly when standard therapies are ineffective. Early diagnosis and hormone replacement therapy are critical as delayed recognition may lead to life-threatening deterioration, but the condition remains reversible with appropriate management.

Indexed as

adrenal insufficiencyadrenocorticotropindepressionhydrocortisoneisolated ACTH deficiency

Identifiers

PMID41743173
PMCPMC12930356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.